Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk

Diabetes

Volumn 61, Issue 2, 2012, Pages 524-530

  Marquez, Marcel ^a   Huyvaert, Marlène ^a   Perry, John R B ^b,c   Pearson, Richard D ^b   Falchi, Mario ^d   Morris, Andrew P ^b   Vivequin, Sidonie ^a   Lobbens, Stéphane ^a   Yengo, Loïc ^a   Gaget, Stefan ^a   Pattou, Francois ^e   Poulain Godefroy, Odile ^a   Charpentier, Guillaume ^f   Carlsson, Lena M S ^g   Jacobson, Peter ^g   Sjöström, Lars ^g   Lantieri, Olivier ^h   Heude, Barbara ⁱ   Walley, Andrew ^d   Balkau, Beverley ⁱ   Marre, Michel ^j,k   Froguel, Philippe ^a,d   Cauchi, Stéphane ^a   more..

^a Institut Pasteur de Lille   (France)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF EXETER   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e INSERM   (France)

^f CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

^h Institute Inter Regional Pour la Santé   (France)

ⁱ CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^j BICHAT HOSPITAL   (France)

^k UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A PROTEIN;

ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; FRANCE; GENE LOCUS; GENE SEQUENCE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; ORAL GLUCOSE TOLERANCE TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING;

EID: 84856513038     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0728     Document Type: Article

References (50)

1. Perry JR, Frayling TM. New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Curr Opin Clin Nutr Metab Care 2008;11:371-377
2. Watanabe RM. The genetics of insulin resistance: where's Waldo? Curr Diab Rep 2010;10:476-484
3. Voight BF, Scott LJ, Steinthorsdottir V, et al.; MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010;42:579-589
4. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-753
5. Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010;11:415-425
6. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008;40:695-701 (Pubitemid 351748875)
7. Schork NJ, Murray SS, Frazer KA, Topol EJ. Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 2009;19:212-219
8. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001;69:124-137 (Pubitemid 32614025)
9. Foti D, Chiefari E, Fedele M, et al. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med 2005;11:765-773 (Pubitemid 41021209)
10. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999;19:5237-5246 (Pubitemid 29339883)
11. Reeves R, Beckerbauer L. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta 2001;1519:13-29 (Pubitemid 32530787)
12. Brunetti A, Manfioletti G, Chiefari E, Goldfine ID, Foti D. Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y). FASEB J 2001;15:492-500 (Pubitemid 32141441)
13. Foti D, Iuliano R, Chiefari E, Brunetti A. A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription. Mol Cell Biol 2003;23:2720-2732 (Pubitemid 36403073)
14. Aiello A, Pandini G, Sarfstein R, et al. HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene. Eur J Cancer 2010;46:1919-1926
15. Akaboshi S, Watanabe S, Hino Y, et al. HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer. Am J Pathol 2009;175:1675-1685
16. Perry JR, McCarthy MI, Hattersley AT, et al. Interrogating type 2 diabetes genome-wide association data using a biological pathway-based approach. Diabetes 2009;58:1463-1467
17. Chiefari E, Tanyolaç S, Paonessa F, et al. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA 2011;305:903-912
18. Garg A. HMGA1, a novel locus for type 2 diabetes mellitus. JAMA 2011;305:938-939
19. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445:881-885
20. Lièvre M, Marre M, Chatellier G, et al.; DIABHYCAR Study Group. The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. Control Clin Trials 2000;21:383-396
21. Marre M, Lievre M, Chatellier G, Mann JF, Passa P, Ménard J; DIABHYCAR Study Investigators. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ 2004;328:495
22. Lafay L, Basdevant A, Charles MA, et al. Determinants and nature of dietary underreporting in a free-living population: the Fleurbaix Laventie Ville Santé (FLVS) Study. Int J Obes Relat Metab Disord 1997;21:567-573 (Pubitemid 27273503)
23. Patterson K. 1000 genomes: a world of variation. Circ Res 2011;108:534-536
24. Wareham NJ, Phillips DI, Byrne CD, Hales CN. The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 1995;12:931
25. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470 (Pubitemid 29418240)
26. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 2002;51(Suppl. 1):S212-S220 (Pubitemid 34761518)
27. Walley AJ, Jacobson P, Falchi M, et al. Differential co-expression analysis of obesity-associated networks in human subcutaneous adipose tissue. Int J Obes. 22 March 2011 [Epub ahead of print]
28. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin: rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002;30:97-101
29. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-150 (Pubitemid 36150192)
30. Chen WM, Abecasis GR. Family-based association tests for genomewide association scans. Am J Hum Genet 2007;81:913-926 (Pubitemid 47580246)
31. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560 (Pubitemid 37088507)
32. Agresti A. Categorical Data Analysis. Hoboken, NJ, Wiley, 2002
33. DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 2007;28:105-114 (Pubitemid 44937874)
34. Cohen J. Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ, Lawrence Erlbaum, 1988
35. Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002;3:391-397 (Pubitemid 34506720)
36. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008;9:356-369 (Pubitemid 351556063)
37. Barrett JC, Cardon LR. Evaluating coverage of genome-wide association studies. Nat Genet 2006;38:659-662 (Pubitemid 43927307)
38. Sakul H, Pratley R, Cardon L, Ravussin E, Mott D, Bogardus C. Familiality of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in Pima Indians. Am J Hum Genet 1997;60:651-656 (Pubitemid 27097615)
39. Elbein SC, Hasstedt SJ, Wegner K, Kahn SE. Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. J Clin Endocrinol Metab 1999;84:1398-1403 (Pubitemid 30644406)
40. Watanabe RM, Valle T, Hauser ER, et al. Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered 1999;49:159-168 (Pubitemid 29261381)
41. Lehtovirta M, Kaprio J, Forsblom C, Eriksson J, Tuomilehto J, Groop L. Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins. Diabetologia 2000;43:285-293 (Pubitemid 30163471)
42. Chiefari E, Iiritano S, Paonessa F, et al. Pseudogene-mediated post-transcriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes. Nat Commun 2010;1:40
43. Chiefari E, Paonessa F, Iiritano S, et al. The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol 2009;7:24
44. Darville MI, Terryn S, Eizirik DL. An octamer motif is required for activation of the inducible nitric oxide synthase promoter in pancreatic betacells. Endocrinology 2004;145:1130-1136 (Pubitemid 38280992)
45. Taylor SI, Accili D, Imai Y. Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes 1994;43:735-740
46. Goldfine ID. The insulin receptor: molecular biology and transmembrane signaling. Endocr Rev 1987;8:235-255
47. Taylor SI, Cama A, Accili D, et al. Mutations in the insulin receptor gene. Endocr Rev 1992;13:566-595
48. Mardis ER. Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 2008;9:387-402
49. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol 2008;26:1135-1145
50. Guey LT, Kravic J, Melander O, et al. Power in the phenotypic extremes: a simulation study of power in discovery and replication of rare variants. Genet Epidemiol. 2011 Feb 9 [Epub ahead of print]